ARTICLE | Clinical News
Olopatadine punctal plug delivery system: Phase II started
November 15, 2010 8:00 AM UTC
QLT Inc. (TSX:QLT; NASDAQ:QLTI), Vancouver, B.C. Product: Olopatadine punctal plug delivery system (O-PPDS) Business: Ophthalmic Molecular target: NA Description: Plug delivery system fit into the tea...